Horacio Gabriel Nastri

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 100(Granted Patents)

Location History:

Armonk, NY (US) (2017)
Newton, MA (US) (2012 - 2020)
Needham, MA (US) (2017 - 2024)

Company Filing History:

Years Active: 2012-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884724 - Anti-PD-L1 antibodies and uses thereof (2024-01-30),

2. 10829541 - Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries (2020-11-10),

3. 10759856 - Anti-PD-L1 antibodies and uses thereof (2020-09-01),

4. 10487147 - Anti-PD-L1 antibodies and uses thereof (2019-11-26),

5. 9683028 - Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries (2017-06-20),

6. 9624298 - Anti-PD-L1 antibodies and uses thereof (2017-04-18),

7. 9534054 - Monoclonal antibody directed against CXCR5 (2017-01-03),

8. 9382535 - Methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins (2016-07-05),

9. 8901045 - Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries (2014-12-02),

10. 8288322 - Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries (2012-10-16),

Title: Horacio Gabriel Nastri: Innovator in Antibody Therapeutics

Introduction

Horacio Gabriel Nastri is a prominent inventor based in Newton, MA (US), known for his significant contributions to the field of biotechnology. He holds a total of 10 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents is the development of anti-PD-L1 antibodies and their uses. This application relates to anti-PD-L1 antibodies or antigen-binding fragments, along with nucleic acids encoding these antibodies. The therapeutic compositions aim to enhance T-cell function, thereby upregulating cell-mediated immune responses for the treatment of T cell dysfunctional disorders, including tumor immunity and cancer. Another notable patent involves methods for constructing libraries that display and/or express members of diverse families of peptides, polypeptides, or proteins. This patent outlines methods useful in screening these libraries and identifying the peptides, polypeptides, or proteins produced.

Career Highlights

Horacio has worked with notable companies in the biotechnology sector, including Dyax Corporation and Merck Patent GmbH. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Throughout his career, Horacio has collaborated with esteemed colleagues such as Christel Iffland and Olivier Leger. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Horacio Gabriel Nastri's contributions to the field of biotechnology, particularly in antibody therapeutics, highlight his role as a leading inventor. His innovative patents and collaborations continue to influence advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.